Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and Mosquito-borne diseases and control.
Disease diagnostics using machine learning of B cell and T cell receptor sequences
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins
5 Clinicopathologic Features and Viral Etiologies of Myocarditis in Post-Mortem Examinations
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
How Effective Was the 2014 AUA Cryptorchidism Guideline? A Multi-institutional Evaluation
Hemagglutination Inhibition Assay for Quantitative Measurement of Antibody Responses to Influenza Virus
Molecular Methods for Identification of Microorganisms
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
An intranasal ASO therapeutic targeting SARS-CoV-2
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
Human Monkeypox without Viral Prodrome or Sexual Exposure, California, USA, 2022
SARS-CoV-2 RNA and N Antigen Quantification via Wastewater at the Campus Level, Building Cluster Level, and Individual-Building Level
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics
1060. Duration of Seroprevalence among Individuals Previously Infected with SARS-CoV-2 and their Household Contacts
1927. Use of a SARS-CoV-2 Strand-specific Assay to evaluate for Prolonged Viral Replication among Hospitalized Patients. Tertiary Care Center, California 2020–2022
14. Monkeypox viral detection from different body sites. Northern California, June–July 2022
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection
Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19